HDAC inhibitors have been used to treat neurodegenerative diseases due to their potential neuroprotective mechanisms through upregulating neurotrophic factors, preventing neurotoxic proteins and peptides from accumulating, and downregulating pro-inflammatory cytokines [24]. This evidence concerns the gene HDAC9 and neurodegenerative disease.